Search results
Moderna (NASDAQ:MRNA) Stock Price Down 3.9% After Insider Selling
ETF DAILY NEWS· 3 days agoModerna, Inc. (NASDAQ:MRNA – Get Free Report)’s share price fell 3.9% during trading on Tuesday following insider selling activity. 1,055,980 shares changed hands during mid-day ...
Moderna stock is lone omen of bird flu pandemic
Reuters· 6 days agoThe recent rise of Moderna’s stock tells a grim tale. The $56 billion company which pioneered a Covid vaccine has seen its market value rise 40% since...
GAMMA Investing LLC Purchases 822 Shares of Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 3 days agoGAMMA Investing LLC grew its position in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 37.8% in the first quarter, HoldingsChannel reports. The fund owned 2,994 shares ...
Moderna (MRNA) Stock Declines While Market Improves: Some Information for Investors
Zacks via Yahoo Finance· 5 days agoModerna (MRNA) ended the recent trading session at $137.90, demonstrating a -1.52% swing from the...
Moderna (MRNA) Stock Declines While Market Improves: Some Information for Investors
Zacks· 6 days agoFree Report) ended the recent trading session at $137.90, demonstrating a -1.52% swing from the preceding day's closing price. Coming into today, shares of the biotechnology company had gained ...
Moderna, Inc. (NASDAQ:MRNA) Shares Bought by Wellington Management Group LLP
ETF DAILY NEWS· 6 days agoWellington Management Group LLP lifted its holdings in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 28.8% in the 4th quarter, according to the company in its most ...
Moderna Stock Soars on Cutting-Edge Personalized Cancer Vaccines | Investing.com
Investing.com· 6 days agoStocks Analysis by MarketBeat.com (Jea Yu) covering: Merck & Company Inc, Amgen Inc, Biogen Inc,...
Gateway - Quartz
Quartz· 4 days agoModerna stock jumped 7% during premarket trading on Thursday after the pharma company, known for its mRNA COVID-19 vaccine, reported a profit of $217 million in its fourth ...
Market Whales and Their Recent Bets on MRNA Options - Moderna (NASDAQ:MRNA)
Benzinga· 3 days agoLoading... Loading... Investors with a lot of money to spend have taken a bullish stance on Moderna MRNA . And retail traders should know. We noticed this today when the trades ...
Gateway - Quartz
Quartz· 4 days agoModerna said Tuesday that its updated COVID-19 vaccine demonstrated a stronger immune response than its current jab in results from a phase-3 clinical trial. The pharma < ...
